id: methadone_continuation_during_incarceration_to_non_fatal_overdose_post_release
name: Methadone Treatment Continuation During Incarceration â†’ Non-Fatal Overdose Post-Release
from_node:
  node_id: methadone_continuation_during_incarceration
  node_name: Methadone Treatment Continuation During Incarceration
to_node:
  node_id: non_fatal_overdose_post_release
  node_name: Non-Fatal Overdose Post-Release
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Continuation of methadone during incarceration maintains opioid tolerance
  regulation and prevents physiological destabilization'
- 'Step 2: Maintained treatment prevents withdrawal-related medication discontinuation
  that increases vulnerability to overdose'
- 'Step 3: Sustained therapeutic medication levels reduce craving and unsupervised
  opioid use upon release'
- 'Step 4: Lower likelihood of relapse to illicit opioid use reduces exposure to substances
  of unknown potency that cause overdose'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Alissa Haas et al. 2021. "Post-incarceration outcomes for individuals
    who continued methadone treatment while in Connecticut jails, 2014-2018.." *Drug
    and alcohol dependence*. https://doi.org/10.1016/j.drugalcdep.2021.108937
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.408904'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
